Lv1
50 积分 2025-03-29 加入
Genomic attributes of prostate cancer across primary and metastatic noncastrate and castrate resistant disease states: a next generation sequencing study of 183 patients
2个月前
已完结
The Selective CDK9 Inhibitor VIP152 Overcame Therapeutic Resistance in Mantle Cell Lymphoma
3个月前
已完结
Novel Multikinase Clk Inhibitor BH-30236 Targets Hematological Malignancies through Alternative Splicing Regulation
4个月前
已完结
Targeting CLK1/SRSF7 axis-dependent alternative splicing sensitizes pancreatic ductal adenocarcinoma to chemotherapy and immunotherapy
4个月前
已完结
Targeting CLK4 inhibits the metastasis and progression of breast cancer by inactivating TGF-β pathway
4个月前
已完结
Alternative splicing in prostate cancer
5个月前
已完结
Exploring the roles of the Cdc2-like kinases in cancers
9个月前
已完结
An overview of cdc2-like kinase 1 (Clk1) inhibitors and their therapeutic indications
9个月前
已完结
皖公网安备34019202002308
